We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Les soins de support générateurs d’effets indésirables. Paradigmes à résoudre Primum non nocere...
- Authors
Scotté, F.; Di Palma, M.
- Abstract
Therapeutics in supportive care are prescribed to diminish side effects of cancer therapies and improve quality of life during treatments. They may have adverse events with their use. Erythropoietins are actually under control, accused to reduce response and survival. Drugs used in supportive care (erythropoietins, analgesic and anti-emesis therapies, biphosphonates), will be analysed in their benefit-risk impact. These treatments have to follow guidelines, published to avoid toxicities and protect patients from bad supportive care therapies.
- Subjects
THERAPEUTICS; CLINICAL medicine; MEDICINE; CANCER treatment; CANCER hospitals
- Publication
Oncologie (Tech Science Press), 2007, Vol 9, p41
- ISSN
1292-3818
- Publication type
Article
- DOI
10.1007/s10269-007-0723-0